本页面由Tiger Trade Technology Pte. Ltd.提供服务

BioLine Rx

2.15
-0.0200-0.92%
成交量:6,173
成交额:1.35万
市值:1,070.32万
市盈率:-1.36
高:2.27
开:2.27
低:2.11
收:2.17
52周最高:4.15
52周最低:2.11
股本:497.82万
流通股本:471.65万
量比:0.79
换手率:0.13%
股息:- -
股息率:- -
每股收益(TTM):-1.5822
每股收益(LYR):-0.2856
净资产收益率:-55.27%
总资产收益率:-19.82%
市净率:0.78
市盈率(LYR):-7.53

数据加载中...

2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/19

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/23

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/11/03

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/01

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/26

招股说明书

F-1 - Registration statement for certain foreign private issuers
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/02

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/05/20

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]